SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+41.76%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$164M
AUM Growth
+$164M
(+90%)
Cap. Flow
+$29M
Cap. Flow
% of AUM
17.7%
Top 10 Holdings %
Top 10 Hldgs %
48.71%
Holding
75
New
26
Increased
18
Reduced
14
Closed
15
Top Buys
| 1 |
Zymeworks
ZYME
|
$13M |
| 2 |
AstraZeneca
AZN
|
$7.2M |
| 3 |
Prothena Corp
PRTA
|
$7.06M |
| 4 |
QuidelOrtho
QDEL
|
$6.91M |
| 5 |
Sarepta Therapeutics
SRPT
|
$5.53M |
Top Sells
| 1 |
Larimar Therapeutics
LRMR
|
$16.9M |
| 2 |
Grifois
GRFS
|
$7.8M |
| 3 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$7.29M |
| 4 |
Zynex
ZYXI
|
$4.28M |
| 5 |
AGN
Allergan plc
AGN
|
$2.59M |
Sector Composition
| 1 | Healthcare | 95.78% |
| 2 | Real Estate | 0.92% |
| 3 | Communication Services | 0% |
